BSX
BOSTON SCIENTIFIC CORP
Surgical & Medical Instruments & Apparatus- 売上
- $20.1bn
- 時価総額
- $67.9bn
株価 $46.00 · 100株 4,600円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $14.2bn | $16.7bn | $20.1bn |
| 成長率 | — | 17.6% | 19.9% |
| 総利益 | $9.9bn | $11.5bn | $13.9bn |
| 総利益率 | 69.5% | 68.6% | 69.0% |
| 販管費 | $5.2bn | $6.0bn | $6.9bn |
| 販管費率 | 36.4% | 35.7% | 34.3% |
| 営利 | $2.3bn | $2.6bn | $3.6bn |
| 営利率 | 16.5% | 15.5% | 18.0% |
| 純利益 | $1.6bn | $1.8bn | $2.9bn |
| PBR | 3.5 | 3.1 | 2.8 |
| PSR | 4.8 | 4.1 | 3.4 |
| PGPR | 6.9 | 5.9 | 4.9 |
| PER | 43 | 37 | 23 |
| ﾈｯﾄｷｬｯｼｭ | ▲$7.7bn | ▲$8.6bn | ▲$9.2bn |
| EV/EBITDA | 21.4 | 19.7 | 15.5 |
| Rule of 40 | — | 33% | 38% |
| セールス効率 | — | 201% | 262% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）